FTC Says Illumina Case Too Simple For Extra Experts

By Bryan Koenig (August 3, 2021, 7:43 PM EDT) -- Federal Trade Commission staffers have urged an agency administrative law judge to reject Illumina's bid for extra experts beyond the normal limit of five as the biotech company defends its proposed $8 billion plan to reacquire cancer testing company Grail, arguing additions are only permitted in extraordinary circumstances....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!